Phase II Study of FOLFIRINOX Chemotherapy for Treatment of Advanced Gastric, Gastro-oesophageal Junction, and Oesophageal Tumours
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2018
At a glance
- Drugs Trastuzumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 20 Jan 2018 Results (n=58) presented at the 2018 Gastrointestinal Cancers Symposium
- 09 Jan 2018 Planned End Date changed from 28 Feb 2021 to 31 May 2021.
- 09 Jan 2018 Planned primary completion date changed from 28 Feb 2018 to 31 May 2018.